Refine by
Industries served
- Medical / Health Care
- Monitoring and Testing
- Chemical & Pharmaceuticals
- Health and Safety
- Environmental
- Water and Wastewater
- Food and Beverage
- Energy
- Oil, Gas & Refineries
- Agriculture
- Air and Climate
- Manufacturing, Other
- Mining
- Aerospace & Air Transport
- Logistics
- Pulp & Paper
- Waste and Recycling
- Soil and Groundwater
- Government
- Publishing / Media / Marketing
Oncology Suppliers Serving Peru
326 companies found
based inManchester, UNITED KINGDOM
Yourgene Health is a leading international molecular diagnostics group with an integrated portfolio of technologies and services to enable genomic medicine. Our mission to enable scientific advances to positively impact human health remains at the ...
At Yourgene Genomic Services we believe every patient can benefit from understanding their unique genomic ...
based inParis, FRANCE
Ipsen is a global biopharmaceutical group dedicated to improving lives and health outcomes through innovative medicines in Oncology, Neuroscience and Rare Disease. We also have a well-established and successful Consumer Healthcare business. We are ...
based inMysore, INDIA
Glowtronics is an ISO 13485:2016, ISO 9001:2015 and registered certified company. Founded in 1986, we have gradually grown to be worldwide OEM and ODM manufacturers of high-precision components, medical devices, medical components and subassemblies. ...
The chemo perfusion set is a specially designed hollow needle used with a chemotherapy port. The bevelled tip of a huber needle will not remove a core of silicone from your port—this prevents a chunk of silicone or skin from lodging in your ...
based inLondon, UNITED KINGDOM
Seacross Pharmaceuticals Ltd. is a multinational pharmaceutical corporation with a strong focus on delivering efficient and advanced medicines to meet the patients’ needs globally. We are heavily investing in the R&D, and also specialised in ...
based inCambridge, MASSACHUSETTS (USA)
Foundation Medicine was founded in 2010 with a mission to bring deep molecular information to the point of care for every patient living with advanced cancer. We’re an essential partner to patients, physicians, researchers, and biopharma ...
Our genomic information knowledgebase is continuously evolving, informed by every clinical sample sequenced with Foundation Medicine’s comprehensive genomic profiling tests. You can also access a unique clinicogenomic data set through our ...
based inTampere, FINLAND
Modulight designs and manufactures lasers and optics for personalized medicine and better life. We provide biomedical lasers for oncology, genetics and ophthalmology, supporting laser solutions like system integration service and laser design & ...
based inMöhrendorf, GERMANY
QRM has a legacy spanning over 25 years in the design and manufacturing of phantoms for diverse medical imaging modalities. Initially focusing on lung imaging in CT and bone densitometry in DXA and CT, the company has since broadened its catalog to ...
The Comprehensive Electron Density Phantom is designed for calibrating the Hounsfield Unit (HU) relative to electron density in CT radiotherapy treatment plans, ensuring optimal dosage for patients. This advanced phantom includes a water-equivalent ...
based inCambridge, MASSACHUSETTS (USA)
Mersana is a biopharmaceutical company specializing in the discovery and development of antibody-drug conjugate (ADC) therapies to treat patients fighting cancer. Leveraging decades of industry learnings, we have developed proprietary and highly ...
Once ADCs release their cytotoxic payload into targeted cells, the drug is often able to cross cell membranes, entering and potentially killing neighboring cells whether those cells are cancerous or not. This effect is called bystander-killing, ...
based inRichmond, BRITISH COLUMBIA (CANADA)
BioMark is an oncology-focused company with advanced near-to- market liquid biopsy diagnostic technologies. Our technology improves patient comfort, outcomes and early cancer detection. Biomark owns various intellectual properties, developed for the ...
BioMark’s initial liquid biopsy assay detects SSAT1 using an FDA approved drug. SSAT1 is an enzyme with elevated levels in numerous cancers. The assay targets a well researched and understood metabolic pathway. BioMark of a few unique ...
based inCanoga Park, CALIFORNIA (USA)
US Nuclear Corp is a publicly traded holding company, Ticker UCLE, with four subsidiaries specializing in designing and manufacturing radiation, chemical, and biological instrumentation and systems for Nuclear Power and nuclear medicine safety and ...
based inSunnyvale, CALIFORNIA (USA)
Over a decade ago, Cepheid set the standard for innovation in automated molecular diagnostics — and we’ve never looked back. Today, even with the largest installed base of any molecular platform, Cepheid is constantly innovating and evolving its ...
based inRedmond, WASHINGTON (USA)
SystImmune Inc. is a biopharmaceutical company focused on the treatment of cancer through developing novel therapeutic bi-specific, and multi-specific antibodies, as well as antibody-drug conjugates (ADCs). Our objective is to create biologics that ...
This Specificity Enhanced Bi-specific Antibody (SEBA) is of the oncology therapeutic class that bind functional proteins on the surface of cells, in this molecule to block growth signals that cancer cells depend on for survival. ...
based inXiamen, CHINA
Amoy Diagnostics Co., Ltd. (AmoyDx) is an R&D based diagnostic company, focusing on molecular diagnostics for oncology precision medicine. With completely independent intellectual property rights of ADx-ARMS®, Super-ARMS®, ddCapture® and ADx-HANDLE® ...
Lung cancer is one of the most common malignant tumor, and 80~85% of lung cancers are non-small cell lung cancer (NSCLC). There are many driver mutations in NSCLC. The frequency of mutations in patients with NSCLC for the EGFR gene is 10~35%, for ...
based inCambridge, MASSACHUSETTS (USA)
The exponential growth of biomedical data, driven by the adoption of electronic medical records (EMRs), provides an unprecedented opportunity to create transformative technologies and products in healthcare. nference partners with medical centers to ...
We offer a vertically integrated, end-to-end solutions and software to make the most of your data. Maximizing your data to improve patient outcomes. We partner with you to securely process and transform your raw unstructured and semi-structured EMR ...
based inOttawa, SWITZERLAND
Orion Biotechnology is unlocking the therapeutic potential of previously undruggable G Protein-Coupled Receptors (GPCRs) with a novel drug modality, proven discovery platform and best-in-class molecules. The company is advancing a diversified ...
G Protein-Coupled Receptors (GPCRs) are involved in a wide range of physiological and pathological processes and represent a large class of drug targets accounting for >30% of all drugs on the market. These drugs, however, only cover 15% of the ...
based inShanghai City, CHINA
Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ('Fosun Pharma'; stock code: 600196. SH, 02196. HK) is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China. Fosun Pharma directly operates ...
based inYuseong-gu, SOUTH KOREA
We strive to become a leading biotech company that contributes to human health and well-being by providing innovative therapeutic antibodies to patients with unmet medical needs. We have been committed to developing novel antibody therapeutics since ...
Depending on antigen presentation patterns on target cell types and the related drug MOA, various bispecific platforms (DIG-body, PIG-body and TIG-body) are adopted in our antibody engineering strategy. Currently, immuno-oncology ...
based inSariyer, TURKEY
GPC Union is a worldwide pharmaceutical supplier company cooperating with different high class manufacturers and brands for the entire global supply chain. GPC Pharmaceutical Wholesaler is the major corporate who experted on procurement of ...
In addition to the traditional drugs used in the treatment of oncological diseases, the frequency of which is increasing day by day, we supply global oncological drugs with smart drug technology and deliver them to ...
based inDaresbury, UNITED KINGDOM
Point of Care (PoC) medical diagnostics is a $ multi-billion global market. Driven by patient need for self monitoring and healthcare cost savings, hand-held devices or readers offering rapid diagnostic test results are fast replacing often slow and ...
Bio-AMD’s planned Generic PoC Magnetic Immunoassay Detection System (‘MIDS’), is expected to have a significantly enhanced sensitivity based on magnetic nano-particle manipulation and detection, capable of interpreting results on a ...
based inTampa, FLORIDA (USA)
Concept Medical is driving innovation in medical devices, with a focus on developing technologies for drug delivery with a strong emphasis on intellectual property. Based in Tampa, Florida; Concept Medical has always striven to find solutions to ...